Velano Vascular reels in $25M to keep building blood-draw business
The San Francisco-based company hopes its PIVO device, which uses an existing catheter already inserted in patients to draw blood, becomes the standard in hospitals nationwide.
The San Francisco-based company hopes its PIVO device, which uses an existing catheter already inserted in patients to draw blood, becomes the standard in hospitals nationwide.
Good news for people afraid of needles and/or blood. Seventh Sense Biosystems' TAP device got its first clearance as a blood collection tool on Thursday. The all-in-one system draws from the patient's capillaries with no visible needles or blood.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sutter Health network has become the latest health system to use Velano Vascular's PIVO blood draw device, an FDA-cleared device that uses a patient’s existing, peripheral IV line to draw blood.
Cleveland-based University Hospitals Case Medical Center announced today its collaboration with Velano, making it the first major U.S. academic medical center to commercially adopt the company’s PIVO innovation.
Two years after the city of Philadelphia launched a $3 million seed fund, the fund has invested in a medical device company — one of four companies to receive investments topping $700,000 and the only healthcare business among them. Velano Vascular received $400,000 from the fund. The medical device company is developing a needle-free approach […]